Canada markets closed

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3200-0.0600 (-4.35%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 45.73M
Enterprise Value 40.58M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.87
Price/Book (mrq)1.71
Enterprise Value/Revenue 0.78
Enterprise Value/EBITDA -2.24

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3-56.15%
S&P500 52-Week Change 320.07%
52 Week High 37.9700
52 Week Low 31.2100
50-Day Moving Average 31.7995
200-Day Moving Average 32.9351

Share Statistics

Avg Vol (3 month) 3156.18k
Avg Vol (10 day) 362.06k
Shares Outstanding 534.64M
Implied Shares Outstanding 635.39M
Float 824.98M
% Held by Insiders 117.92%
% Held by Institutions 148.10%
Shares Short (Mar 28, 2024) 4706.67k
Short Ratio (Mar 28, 2024) 42.64
Short % of Float (Mar 28, 2024) 42.12%
Short % of Shares Outstanding (Mar 28, 2024) 42.04%
Shares Short (prior month Feb 29, 2024) 41.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -35.75%
Operating Margin (ttm)-39.39%

Management Effectiveness

Return on Assets (ttm)-18.80%
Return on Equity (ttm)-58.25%

Income Statement

Revenue (ttm)52.35M
Revenue Per Share (ttm)1.51
Quarterly Revenue Growth (yoy)16.30%
Gross Profit (ttm)N/A
EBITDA -19.01M
Net Income Avi to Common (ttm)-18.71M
Diluted EPS (ttm)-0.5400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)43.65M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)38.5M
Total Debt/Equity (mrq)143.01%
Current Ratio (mrq)5.52
Book Value Per Share (mrq)0.77

Cash Flow Statement

Operating Cash Flow (ttm)-5.25M
Levered Free Cash Flow (ttm)3.37M